Arktos Pharma terminals

This page lists **Arktos Pharma terminals**.

v. 7.09.41
 Welcome text
==== Arktos Pharma - Confidential ====
 Body
====================================================== Arktos Pharma =
= Protein Sequencer ================================================

=====================================================\* !! System Error !! \*===============================================

 ::: Error Code 555 :::

Unable to run protein sequencer at this time.

## Cargobot Control Terminal

v. 7.09.41
 Welcome text
==== Arktos Pharma - Confidential ====
 Body
====================================================== Arktos Pharma =
= Cargobot Control ================================================

### Check current flight schedule

Accessing Relay Network.....

=====================================================\* !! System Error !! \*===============================================

 Error Code 314 :::

Unable to establish contact with flight relays at this time.

## Arktos Lab Terminal

 Welcome text
==== Arktos Pharma - Confidential ====
 Body
Notice: The data you are accessing on this terminal is confidential, proprietary information solely owned by Arktos Pharma. If you do not have the proper clearances then you are not authorized to read, change, distribute, or use this data

### Test Log 5-31-77-P3

Test Log 5-31-77-P3

Leaves are showing decreased chlorophyll. Browning not just of the edges, but all the way to the stalk. I think we can say this one is a dud. I thought for sure we'd managed to replicate the results this time. I don't know if it isn't binding is due to the concentration of the distillate or an incompatible sequence. Wouldn't be so bad if we weren't all afraid of running the centrifuge, but after the accident last month, we've all been on edge. Unfortunately it seems that the closest solution we've managed so far becomes volatile when at too great a concentration.

As in, explosively volatile. Luckily no one was hurt.

No full time staff anyway. We always have more interns.

Ugh. I can't believe I have to work on Memorial Day. Arktos isn't paying me enough for this.

### Test Log 4-17-77-P6

Test Log 4-17-77-P6

 =====================================================\* !! System Error !! \*===============================================

 Error Code 141 :::

Log file corrupt.

## Arktos Pharma Terminal

v. 7.09.41
 Welcome text
==== Arktos Pharma - Confidential ====
 Body
Notice: The data you are accessing on this terminal is confidential, proprietary information solely owned by Arktos Pharma. If you do not have the proper clearances then you are not authorized to read, change, distribute, or use this data

### Project Beanstalk

v. 7.09.41
 Welcome text
==== Arktos Pharma - Confidential ====
 Body
Querying Pharmabots . . . . . . . .

Pharmabot NIKY-7E (Test Field 004) - OFFLINE ...

Pharmabot JENY-7E (Test Field 018) - OFFLINE ...

Pharmabot JD-7E (Test Field 014) - OPERATIONAL. STANDING BY ...

Pharmabot LRN-7E (Test Field 007) - OFFLINE ...

Pharmabot MRK-7E (Base unit, no assigned field) - DEPRECATED ...

Warning! Warning! Errors occurred while processing request. All Pharmabots not found.

#### Project Beanstalk Overview

v. 7.09.41
 Welcome text
==== Arktos Pharma - Confidential ====
 Body
ARKTOS PHARMA - PROJECT BEANSTALK

==== Proposal ====

The purpose of this research is to evaluate the effectiveness of Arktos Pharma chemical compounds on crop yields. Three distinct experimental formulae will be deployed through the use of an Arktos Pharmabot for consistent and efficient distribution over the test fields. The bot will autonomously spray the designated locations and assess the impact. All data will be transmitted to the Project Beanstalk laboratory at Arktos Pharma headquarters on a regular schedule.

#### Experimental Formulae

Planned usage of the following experimental formulae:

1. Low Z-ano

2. H-E-N Best

3. Agg E

All mixtures have been rendered reasonably stable via a proprietary Arktos Pharma protocol that converts their liquid form to a crystalline matrix resistant to moisture and thermal variation.

Distribution via automated process is required as all three share a significant caustic effect on living tissues. Known symptoms of exposure include: involuntary outbursts of laughter, seepage of blood from mucous membranes, and periodic hallucinations.

#### Distribution Protocol

Pharmabots have been deployed to twenty test field locations in preparation for the project start date, May 1, 2077. They will disburse the formulae over their test field using different methods, measure the growth of their crops, and report their findings.

Each will receive monthly maintenance at their test site but an important aspect of this project is to evaluate the autonomous operations for reliability so other than required repairs the Pharmabots will be strictly left alone.

# |welcome =
= AUTONOMOUS RESEARCH INTELLIGENCE COMPUTER v.4 =
# = Fully Operational =

### Project Paradise

v. 7.09.41
 Welcome text
# = Recreational Drug Development =

Goal: Development of a substance that improves users' calmness, confidence, and social skills.
 Body

#### Automated Log APBL-PD-001A

= AUTONOMOUS RESEARCH INTELLIGENCE COMPUTER v.4 =

= Log: APBL-PD-001A =

Project Paradise has begun.

Analyzing results and methodology of Project Genesis and Project White Mouse to formulate an effective plan.

First priority: financial efficiency.

#### Automated Log APBL-PD-002A

= AUTONOMOUS RESEARCH INTELLIGENCE COMPUTER v.4 =

= Log: APBL-PD-002A =

Analysis complete.

Project Paradise will use animal testing and robotic technicians to minimize cost, risk, and development time.

A preliminary formula is now being developed for test subject dispersal.

#### Automated Log APBL-PD-003A

= AUTONOMOUS RESEARCH INTELLIGENCE COMPUTER v.4 =

= Log: APBL-PD-003A =

Formula A has been dispersed to test subjects.

All subjects died within 2 hours. Reformulating.

#### Automated Log APBL-PD-004A

= AUTONOMOUS RESEARCH INTELLIGENCE COMPUTER v.4 =

= Log: APBL-PD-004A =

Formulas B through O have been dispersed and iterated upon with no notable successes.

Subjects that consume Formula P exhibit 2 of 3 desired effects and 1 major side effect: Subjects who have not taken Formula P exhibit extreme aggression toward subjects who have taken it.

Based on previous analysis of lab methodology, these results are sufficient to sell the product.

#### Technician Log APBL-PD-001T

= Dr. Jude Mayes =

= Log: APBL-PD-001T =

Could we get an engineer to look at this computer ASAP? The damn thing keeps claiming that the current results are "good enough", citing my lack of hours on the project as an example of proper lab methodology.

Ridiculous. I brought this thing in at the end of White Mouse to make future projects more efficient, not so I could spend time elsewhere. Those time logs need to be corrected, too, please.

### About ARIC-4

ARIC-4 combines state-of-the-art database management and machine learning algorithms to record, organize, and analyze your results in real-time.

No more messy paperwork or mental labor. Just sit back, relax, and watch your experiment unfold!

Vault-Tec is not responsible for any decisions, results, or errors made by this product.

### Warranty

ERROR: VOID WARRANTY

DETAILS: INTERNAL CODE HAS BEEN ALTERED

## Animal Testing Research Terminal

v. 7.09.41
 Welcome text
 ==== Arktos Pharma Biome Lab - Confidential ====
 Body
= PROJECT WHITE MOUSE =
= Dr. Joseph M. Majzoub =
= Prototype Genomic Centrifuge & Feeding Trough =
# = Quarterly Progress Report =

### Quarterly Log APBL-AT-001A

= Dr. Joseph M. Majzoub =

= Log: APBL-AT-001A =

Engineering finalized the blueprints on the centrifuge and trough. Materials are being delivered this month. We expect to have some of the framework built out by the end of the quarter.

I thought they were crazy when they proposed an underground biome lab to me, but this thing is truly a marvel of modern engineering. If we pull this off, we can perform all kinds of testing with variables completely controlled. And the fact that it's away from prying eyes - well, that's a nice bonus.

### Quarterly Log APBL-AT-002A

= Dr. Joseph M. Majzoub =

= Log: APBL-AT-002A =

Both prototypes are built but we're having some problems with electrical on the genomic centrifuge.

The robot's been programmed to handle the animals. I'm all for time saved by automation, but in this case, I really hope it's worth it. The thing talks to everyone like it's talking to a dog.

### Quarterly Log APBL-AT-003A

= Dr. Joseph M. Majzoub =

= Log: APBL-AT-003A =

We're finally up and running with all systems nominal and the techs are working out some minor bugs with the code.

We're submitting a list of animal test subjects to corporate. Currently awaiting approval but we should be good to go soon. I get most of the animals on this list, but a sloth? The biology team is a weird bunch but I guess everyone plays their part.

### Quarterly Log APBL-AT-004A

= Dr. Joseph M. Majzoub =

= Log: APBL-AT-004A =

The list of animal test subjects have been approved. Subjects are being delivered on a daily basis. For the most part they're acclimating to the habitats we built for them. Except for the sloths, but I could have told them that would happen.

We encountered a few issues with the temperature regulator in Habitat B but nothing engineering can't handle. Testing will commence this quarter. We're on track to deliver results that will even blow corporate projections out of the water.

## Food Crop Research Terminal

v. 7.09.41
 Welcome text
 ==== Arktos Pharma Biome Lab - Confidential ====
 Body
= PROJECT GENESIS =
= Dr. Christina Bryan =
= Genetically Modified Food Crop Research =
# = Quarterly Progress Report =

### Quarterly Log APL-FC-001A

= Dr. Christina Bryan =

= Log: APBL-FC-001A =

Phase 1: Creation of simulated models to aid in early identification of issues and make adjustments accordingly.

Phase 2: Formulation of process for DNA extraction, gene cloning, gene design, transformation and backcross breeding.

Phase 3: Initial experimentation conducted in a controlled underground environment to help circumvent increasingly strict governmental regulations.

### Quarterly Log APL-FC-002A

= Dr. Christina Bryan =

= Log: APBL-FC-002A =

Phase 3 is off without a hitch. Studies on genetically enhanced food crops (initially corn, wheat and tomatoes) have started off promising.

Bombarding these vegetables with small doses of radiation in this controlled environment has lead to exponential growth, stronger resistance to insects and time to ripeness cut in half.

If I might add, I've found the crops to be significantly juicer and more flavorful as well.

### Quarterly Log APL-FC-003A

= Dr. Christina Bryan =

= Log: APBL-FC-003A =

We've made great strides towards our goals but have observed potentially negative side-effects as a direct counterpart to each enhanced benefit. Utilizing our methods to alter food crop genomes can greatly improve a condition, but only at the cost of another. Additionally, this modification can also negatively impact its surroundings when later introduced to an uncontrolled environment.

When we consider the escalating global problems of population and food supply, the usefulness of this process becomes clear despite these concerns.

### Quarterly Log APL-FC-004A

= Dr. Christina Bryan =

= Log: APBL-FC-004A =

Perceived advantages of crop enhancement process:

1. Extremely enhanced growth rate

2. Extended life due to natural pest resistance

3. Brand new foods to introduce to market

4. Can feed exponentially increasing population

Perceived disadvantages of crop enhancement process:

1. Decreased nutritional value

2. Increased risk of pathogens

3. Variety of potentially negative side effects

4. Unfavorable diversity

# = ARKTOS ENGINEERING =

### Quarterly Log APBL-ED-001A

= Marianne Ling =

= Log: APBL-ED-003A =

Everything is going to explode if the lab techs try to use the equipment before it's ready. And it will be a very, very costly explosion.

We need our deadline for the centrifuge extended. Period.

### Quarterly Log APBL-ED-002A

= Marianne Ling =

= Log: APBL-ED-003A =

We didn't get our deadline extension. We worked copious hours of overtime. Nothing has exploded - YET. But several lab techs have been electrocuted.

I requested at least 4 months to stablize the system. Corporate gave us 1. Don't say I didn't warn anyone.

### Quarterly Log APBL-ED-003A

= Marianne Ling =

= Log: APBL-ED-003A =

We've gotten some complaints about the Handy Bot. It is specialized to interact with animals, as requested. If it also needs to be specialized to interact with humans, then we need another 2 months with it. And I don't think corporate is willing to delay Project White Mouse for that long.

Other than that, things are mostly not on fire.

### Quarterly Log APBL-ED-004A

= Marianne Ling =

= Log: APBL-ED-003A =

There's been talk of a new automated research AI developed by Vault-Tec. I'll say it now: it's not easy, or fast, to learn a new system. So if we're going to be on the hook to reprogram it, don't expect it to be perfect.